When Professor Petro Terblanche joined biotechnology start-up Afrigen three years ago, she had no idea that the team she was heading up would create the continent’s first mRNA vaccine. But that wasn’t the first time Terblanche had been at the forefront of cutting-edge scientific work. Aisha Abdool Karim spoke to her as part of Spotlight’s Women in Health series.
Passionate about community psychiatry, Professor Lesley Robertson spent the bulk of her career as a psychiatrist pushing for mental health reform in South Africa. Now, as head of the community psychiatry clinical unit at Sedibeng District Health Service, she is still pushing – among others to improve the essential medicines lists for psychiatric medicines and shore up community-based networks of churches, community groups, and assisted living homes as soft landings for people in need. Ufrieda Ho spoke to her as part of Spotlight’s Women in Health series.
South Africa is seeing fewer medication stockouts than in previous years but contraception shortages continue to be a problem in the country, according to a new report from the Stop Stockouts Project. Injectables, the most widely used method in South Africa, accounted for three-quarters of contraception stockouts reported. Aisha Abdool Karim unpacks what this means for women’s sexual and reproductive health.
At one stage during the COVID-19 pandemic, Dr Angela Hartwig was the only doctor at Adelaide Hospital in the Eastern Cape. She also fell ill while pregnant and working, and ended up in a COVID-ward. Despite the challenges the pandemic dished out to health facilities and health workers, especially in rural areas like Adelaide, she remains passionate about rural health. Bienne Huisman spoke to her as part of Spotlight’s Women in Health series.
The worsening climate crisis poses a threat to women and girls and their access to healthcare in the country. Matshidiso Lencoasa argues that although the ongoing climate crisis is daunting, it can serve as an opportunity for budgeting and policy-making processes to centre the most vulnerable and protect women’s right to healthcare.
Elri Voigt summarises some of the latest developments on long-acting therapies for HIV presented at the 2022 International AIDS conference.
Dr Thesla Palanee-Phillips is the Director of Clinical Trials at the Wits Reproductive Health and HIV Institute (Wits RHI) at the University of the Witwatersrand. As part of Spotlight’s Women in Health series, Elri Voigt spoke to her about what set her off into a career in science, the significance of the ASPIRE trial that she co-chaired, and juggling motherhood and her career.
It is estimated that in 2021, around 0.3% of sexually active people in the Western Cape were taking antiretroviral medicines to prevent HIV infection. This is substantially lower than the national estimate of 1%. Elsabé Brits asks why uptake in the Western Cape is lagging behind most other provinces.
Mary Selona, a community activist who heads up the Blood River Advice Centre in Limpopo, is putting women at the centre in her quest for social justice. Whether it is intervening when women are refused PrEP at clinics or in more immediate life-threatening situations relating to gender-based violence, Selona is leading from the front. Ufrieda Ho spoke to her as part of Spotlight’s Women in Health series.
The right to abortion has been catapulted into the spotlight by Dobbs v Jackson, the landmark judgment of the United States Supreme Court that overturned Roe v Wade – a 50-year-old precedent of that court that first recognised the constitutional right to abortion in the US. The recognition of a right to abortion is often the first step towards creating an enabling environment for women to access abortions but in some countries in East and Southern Africa, argue the authors, Dobbs may put brakes on little sparks of hope that emerged in recent years.
One of the hot topics at the recently concluded AIDS 2022 conference held in Montreal, Canada, was how HIV prevention interventions such as pills or injections that prevent HIV infection should be made available to different groups of people. Tiyese Jeranji spoke to some local experts and an activist about the rich set of discussions.
The world stands at an inflection point once more in the war against HIV. For those of us working in the field in South Africa, especially, it feels eerily like the battle that was fought 25 years ago, writes Dr Liesl Page-Shipp.
